Long-term stability of clinical-grade lentiviral vectors for cell therapy-Reference-Cited by-同舟云学术

Long-term stability of clinical-grade lentiviral vectors for cell therapy

Published:2024-03 Issue:1 Volume:32 Page:101186
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Jadlowsky Julie K.^ORCID,Leskowitz Rachel,McKenna Stephen,Karar Jayashree,Ma Yujie,Dai Anlan,Plesa Gabriela,Chen Fang,Alexander Kathleen,Petrella Jennifer,Gong Nan,Hwang Wei-Ting,Farrelly Olivia,Barber-Rotenberg Julie,Christensen Shannon,Gonzalez Vanessa E.,Chew Anne,Fraietta Joseph A.,June Carl H.

Publisher

Elsevier BV

Reference13 articles.

1. Gene transfer in humans using a conditionally replicating lentiviral vector;Levine;Proc. Natl. Acad. Sci. USA,2006

2. Lentiviral vector bioprocess economics for cell and gene therapy commercialization;Comisel;Biochem. Eng. J.,2021

3. Provided by the Journal of Gene Medicine,2023

4. Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?;Bear;Mol. Ther.,2012

5. Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients;Marcucci;Mol. Ther.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights;Frontiers in Immunology;2024-09-05

2. Regulatory landscape and challenges in CAR-T cell therapy development in the US, EU, Japan, and India;European Journal of Pharmaceutics and Biopharmaceutics;2024-08

3. The very stable lentiviral vector;Molecular Therapy - Methods & Clinical Development;2024-03